Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

CLS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

CLS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Celestica Inc(CLS US)

$240.34-13.695.39%Ext:$237.00-3.341.39%(Market Closed · 01:00:02 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Celestica Inc(CLS US)

$240.34-13.695.39%Ext:$237.00-3.341.39%(Market Closed · 01:00:02 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(33)

Expand
  • 10-QQ3ended 30 Sept 202626 Oct
  • 10-QQ2ended 30 Jun 202627 Jul
  • 10-QQ1ended 31 Mar 202627 Apr
  • 10-KFY 2025ended 31 Dec 202527 Feb
  • 10-QQ3ended 30 Sept 202527 Oct 2025
  • 10-QQ2ended 30 Jun 202528 Jul 2025
  • 10-QQ1ended 31 Mar 202524 Apr 2025
  • 10-KFY 2024ended 31 Dec 20243 Mar 2025
  • 20-FFY 2023ended 31 Dec 202311 Mar 2024
  • 20-FFY 2022ended 31 Dec 202213 Mar 2023
  • 20-FFY 2021ended 31 Dec 202114 Mar 2022
  • 20-FFY 2020ended 31 Dec 202015 Mar 2021
  • 20-FFY 2019ended 31 Dec 201916 Mar 2020
  • 20-F/AFY 2018ended 31 Dec 201825 Apr 2019
  • 20-FFY 2018ended 31 Dec 201811 Mar 2019

Events(415)

Expand
  • 8-KRegulation FD Disclosure30 Oct
  • 8-K••••➜➜➜••••➜➜➜➜➜➜➜••➜ • • • • ➜ •✓✓ ✓✓ ✓✓ ✓✓•••••••••➜➜➜(In millions of U.S. dollars, except percentages)FY 2025 FY 2024 FY 2023 Revenue $ 12,390.9 $ 9,646.0 $ 7,961.0 Net earnings 832.5 428.0 244.4 Earnings per share - diluted $ 7.16 $ 3.61 $ 2.03 W.A. # of shares (in millions), on a basic basis 115.3 118.1 120.1 W.A. # of shares (in millions), on a diluted basis 116.2 118.7 120.3 Actual # of shares o/s (in millions) as of period end 114.9 116.1 119.0 GAAP Earnings from operations $ 1,040.7 $ 599.3 $ 338.3 A s a perc ent age of revenue 8.4% 6.2% 4.2% Restructuring and other charges (recoveries) 29.7 19.4 12.1 Employee SBC expense 69.8 57.4 55.6 TRS FVAs (253.0) (91.0) - FCC Transitional ADJ - (1.3) (1.2) Amortization of intangible assets (excluding computer software) 39.8 38.8 36.8 Non-GAAP adjusted EBIAT $ 927.0 $ 622.6 $ 441.6 Non-GAAP adjusted operating margin 7.5% 6.5% 5.5% GAAP Net earnings $ 832.5 $ 428.0 $ 244.4 A s a perc ent age of revenue 6.7% 4.4% 3.1% Employee SBC expense 69.8 57.4 55.6 Amortization of intangible assets (excluding computer software) 39.8 38.8 36.8 Restructuring and other charges (recoveries) 29.7 19.4 12.1 IRS Transitional ADJ - - 9.0 Miscellaneous expense (income) 4.9 15.0 (46.6) TRS FVAs (253.0) (91.0) - FCC Transitional ADJ - (1.3) (1.2) Adjustments for taxes (20.5) (5.5) (14.3) Non-GAAP adjusted net earnings $ 703.2 $ 460.8 $ 295.8 A s a perc ent age of revenue 5.7% 4.8% 3.7% Non-GAAP adjusted earnings per share - diluted $ 6.05 $ 3.88 $ 2.46 GAAP Non-GAAP operating earnings (adjusted EBIAT) Non-GAAP adjusted net earnings and non-GAAP adjusted EPS (In millions of U.S. dollars, except percentages and per share amounts)Q1 2026 Q2 2026 Q3 2026 YTD 2026 FY 2025 FY 2024 FY 2023 GAAP Earnings from operations $ 272.1 $ 458.3 $ 460.0 $ 1,190.4 $ 1,040.7 $ 599.3 $ 338.3 Multiplier to annualize earnings 4 4 4 1.333 1 1 1 Annualized GAAP earnings from operations $ 1,088.4 $ 1,833.2 $ 1,840.0 $ 1,586.8 $ 1,040.7 $ 599.3 $ 338.3 Average Net Invested Capital for the period $ 2,611.4 $ 2,786.6 $ 3,066.6 $ 2,839.0 $ 2,498.7 $ 2,292.4 $ 2,132.5 GAAP ROIC % 41.7% 65.8% 60.0% 55.9% 41.6% 26.1% 15.9% Non-GAAP adjusted EBIAT $ 325.2 $ 386.3 $ 496.1 $ 1,207.6 $ 927.0 $ 622.6 $ 441.6 Multiplier to annualize earnings 4 4 4 1.333 1 1 1 Annualized non-GAAP adjusted EBIAT $ 1,300.8 $ 1,545.2 $ 1,984.4 $ 1,609.7 $ 927.0 $ 622.6 $ 441.6 Average Net Invested Capital for the period $ 2,611.4 $ 2,786.6 $ 3,066.6 $ 2,839.0 $ 2,498.7 $ 2,292.4 $ 2,132.5 Non-GAAP adjusted ROIC % 49.8% 55.5% 64.7% 56.7% 37.1% 27.2% 20.7% Net invested capital consists of: Total assets $ 8,260.0 $ 9,787.6 $ 15,138.5 $ 15,138.5 $ 7,213.1 $ 5,988.2 $ 5,890.5 Less: cash (378.0) (535.7) (3,961.3) (3,961.3) (595.6) (423.3) (370.4) Less: ROU assets (operating and finance leases) (199.9) (218.5) (274.5) (274.5) (173.1) (180.8) (170.0) (5,021.7) (6,120.7) (7,682.3) (7,682.3) (3,882.0) (2,969.2) (3,168.4) Net invested capital at period end $ 2,660.4 $ 2,912.7 $ 3,220.4 $ 3,220.4 $ 2,562.4 $ 2,414.9 $ 2,181.7 Non-GAAP adjusted ROIC Less: accounts payable, accrued and other liabilities and provisions (excluding finance and operating lease liabilities) and income taxes payable (In millions of U.S. dollars, except percentages)(In millions of U.S. dollars, except percentages) FY 2025 FY 2024 FY2023 GAAP tax expense $ 150.7 $ 104.2 $ 61.6 Earnings from operations 1,040.7 599.3 338.3 Finance costs (56.8) (57.0) (80.3) Interest income 4.2 4.9 1.4 Miscellaneous Income (Expense) (4.9) (15.0) 46.6 $ 983.2 $ 532.2 $ 306.0 GAAP effective tax rate1 15% 20% 20% Adjusted tax expense (non-GAAP) $ 171.2 $ 109.7 $ 75.9 Adjusted operating earnings (non-GAAP) 927.0 622.6 441.6 Finance costs (56.8) (57.0) (80.3) Interest income 4.2 4.9 1.4 IRS Transitional ADJ - - 9.0 $ 874.4 $ 570.5 $ 371.7 Adjusted effective tax rate (non-GAAP)2 20% 19% 20%27 Oct
  • 8-KResults of Operations and Financial Condition26 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Sep
  • 8-KEntry into a Material Definitive Agreement7 Aug
  • 8-KResults of Operations and Financial Condition27 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers6 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders19 May
  • 8-KEntry into a Material Definitive Agreement28 Apr
  • 8-KResults of Operations and Financial Condition27 Apr
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers24 Mar
  • 8-KOther Events29 Jan
  • 8-KResults of Operations and Financial Condition28 Jan
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers5 Dec 2025
  • 8-KRegulation FD Disclosure30 Oct 2025

Insider Ownership(165)

Expand
  • Form 4Ankenmann Todd5 Nov
  • Form 4Dorwart Steven Gregg5 Nov
  • Form 4Chawla Mandeep5 Nov
  • Form 4CASCELLA ROBERT1 Oct
  • Form 4Kale Jill1 Oct
  • Form 3Ankenmann Todd1 Oct
  • Form 4Cooper Todd C24 Sep
  • Form 4MIONIS ROBERT24 Sep
  • Form 4MIONIS ROBERT14 Aug
  • Form 4MIONIS ROBERT12 Aug
  • Form 4Reeder David12 Aug
  • Form 4Colpitts Christopher W.12 Aug
  • Form 4Maletira Amar12 Aug
  • Form 4KOELLNER LAURETTE T12 Aug
  • Form 4Kale Jill12 Aug

Beneficial Ownership(121)

Expand
  • SC 13G/ACELESTICA INC5 Feb
  • SC 13GCELESTICA INC21 Jan
  • SC 13G/ACELESTICA INC14 Aug 2025
  • SC 13G/ACELESTICA INC12 May 2025
  • SC 13G/ACELESTICA INC14 Feb 2025
  • SC 13G/ACELESTICA INC8 Jan 2025
  • SC 13GCELESTICA INC12 Nov 2024
  • SC 13G/ACELESTICA INC7 Nov 2024
  • SC 13GCELESTICA INC10 May 2024
  • SC 13G/ACELESTICA INC12 Feb 2024
  • SC 13GCELESTICA INC8 Feb 2024
  • SC 13G/ACELESTICA INC12 Jan 2024
  • SC 13G/ACELESTICA INC8 Sep 2023
  • SC 13D/ACELESTICA INC4 Aug 2023
  • SC 13G/ACELESTICA INC7 Jul 2023

Other Ownership(59)

Expand
  • Form 144Cooper Todd C23 Sep
  • Form 144Chawla Mandeep31 Jul
  • Form 144MIONIS ROBERT31 Jul
  • Form 144Chawla Mandeep15 Jun
  • Form 144MIONIS ROBERT15 Jun
  • Form 144Wilson Michael Max19 May
  • Form 144Muller Luis A23 Mar
  • Form 144Phillips Jason6 Feb
  • Form 144Etienvre Yann L2 Feb
  • Form 144Wong Leila2 Feb
  • Form 144Parker Douglas Michael2 Feb
  • Form 144Cooper Todd C2 Feb
  • Form 144Wong Leila1 Dec 2025
  • Form 144Etienvre Yann L1 Dec 2025
  • Form 144Agrawal Alok K.30 May 2025

Proxies(7)

Expand
  • ARSAnnual report to security holders9 Apr
  • DEFA14ADefinitive additional materials9 Apr
  • DEF 14ADefinitive proxy statement9 Apr
  • ARSAnnual report to security holders29 Apr 2025
  • DEFA14ADefinitive additional materials29 Apr 2025
  • DEF 14ADefinitive proxy statement29 Apr 2025
  • PRE 14APreliminary proxy statement7 Mar 2025

Registrations(52)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))6 Aug
  • FWPFree writing prospectus5 Aug
  • FWPFree writing prospectus5 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))5 Aug
  • S-8Registration statement (employee benefit plan)30 Jul 2025
  • S-8Registration statement (employee benefit plan)30 Jul 2025
  • S-3ASRAutomatic shelf registration statement (S-3)3 Mar 2025
  • S-8Registration statement (employee benefit plan)24 Oct 2024
  • 8-A12B/ARegistration of securities (Section 12(b), amendment)25 Apr 2024
  • 424B7Prospectus filing (Rule 424(b)(7))3 Aug 2023
  • 424B7Prospectus filing (Rule 424(b)(7))2 Aug 2023
  • S-8Registration statement (employee benefit plan)27 Jul 2023
  • F-3ASRAutomatic shelf registration statement (F-3)27 Jul 2023
  • 424B7Prospectus filing (Rule 424(b)(7))7 Jun 2023
  • 424B7Prospectus filing (Rule 424(b)(7))6 Jun 2023

Filing Review Correspondence(4)

Expand
  • CORRESPFiling review correspondence15 Sep 2016
  • CORRESPFiling review correspondence7 May 2015
  • CORRESPFiling review correspondence
  • CORRESPFiling review correspondence

SEC Orders And Notices(7)

Expand
  • CT ORDERConfidential treatment order3 Apr 2018
  • CT ORDERConfidential treatment order29 Mar 2017
  • CT ORDERConfidential treatment order11 Apr 2016
  • CT ORDERConfidential treatment order15 May 2015
  • CT ORDERConfidential treatment order23 Jun 2014
  • CT ORDERConfidential treatment order21 Jun 2013
  • CT ORDERConfidential treatment order12 Jun 2012

Tender Offers And Going Private(27)

Expand
  • SC TO-I/ATender offer statement (issuer, amendment)5 Jun 2015
  • SC TO-I/ATender offer statement (issuer, amendment)2 Jun 2015
  • SC TO-I/ATender offer statement (issuer, amendment)7 May 2015
  • SC TO-ISCHEDULE TO-I REG27 Apr 2015
  • SC TO-CTender offer statement (communication)21 Apr 2015
  • SC TO-CSC TO-I21 Apr 2015
  • SC TO-I/ATender offer statement (issuer, amendment)7 Dec 2012
  • SC TO-I/ATender offer statement (issuer, amendment)4 Dec 2012
  • SC TO-I/ASC TO-I19 Nov 2012
  • SC TO-I/ATender offer statement (issuer, amendment)6 Nov 2012
  • SC TO-ITender offer statement (issuer)29 Oct 2012
  • SC TO-CTender offer statement (communication)25 Oct 2012
  • SC TO-CTender offer statement (communication)24 Oct 2012
  • SC TO-I/ATender offer statement (issuer, amendment)8 Nov 2005
  • SC TO-I/ATender offer statement (issuer, amendment)8 Nov 2005

Other(14)

Expand
  • SDSD5 May
  • SDSD7 May 2025
  • SDSD5 May 2023
  • SDSD5 May 2022
  • SDSD6 May 2021
  • SDSD4 May 2020
  • SDSD13 May 2019
  • SDSD17 May 2018
  • SDSD26 May 2017
  • SDSD25 May 2016
  • SDSD22 May 2015
  • SDSD2 Jun 2014
  • Form 25AUTO-GENERATED PAPER DOCUMENT27 Sep 2005
  • SDSD

Financials(33)

Expand
  • 10-QQ3ended 30 Sept 202626 Oct
  • 10-QQ2ended 30 Jun 202627 Jul
  • 10-QQ1ended 31 Mar 202627 Apr
  • 10-KFY 2025ended 31 Dec 202527 Feb
  • 10-QQ3ended 30 Sept 202527 Oct 2025
  • 10-QQ2ended 30 Jun 202528 Jul 2025
  • 10-QQ1ended 31 Mar 202524 Apr 2025
  • 10-KFY 2024ended 31 Dec 20243 Mar 2025
  • 20-FFY 2023ended 31 Dec 202311 Mar 2024
  • 20-FFY 2022ended 31 Dec 202213 Mar 2023
  • 20-FFY 2021ended 31 Dec 202114 Mar 2022
  • 20-FFY 2020ended 31 Dec 202015 Mar 2021
  • 20-FFY 2019ended 31 Dec 201916 Mar 2020
  • 20-F/AFY 2018ended 31 Dec 201825 Apr 2019
  • 20-FFY 2018ended 31 Dec 201811 Mar 2019

Events(415)

Expand
  • 8-KRegulation FD Disclosure30 Oct
  • 8-K••••➜➜➜••••➜➜➜➜➜➜➜••➜ • • • • ➜ •✓✓ ✓✓ ✓✓ ✓✓•••••••••➜➜➜(In millions of U.S. dollars, except percentages)FY 2025 FY 2024 FY 2023 Revenue $ 12,390.9 $ 9,646.0 $ 7,961.0 Net earnings 832.5 428.0 244.4 Earnings per share - diluted $ 7.16 $ 3.61 $ 2.03 W.A. # of shares (in millions), on a basic basis 115.3 118.1 120.1 W.A. # of shares (in millions), on a diluted basis 116.2 118.7 120.3 Actual # of shares o/s (in millions) as of period end 114.9 116.1 119.0 GAAP Earnings from operations $ 1,040.7 $ 599.3 $ 338.3 A s a perc ent age of revenue 8.4% 6.2% 4.2% Restructuring and other charges (recoveries) 29.7 19.4 12.1 Employee SBC expense 69.8 57.4 55.6 TRS FVAs (253.0) (91.0) - FCC Transitional ADJ - (1.3) (1.2) Amortization of intangible assets (excluding computer software) 39.8 38.8 36.8 Non-GAAP adjusted EBIAT $ 927.0 $ 622.6 $ 441.6 Non-GAAP adjusted operating margin 7.5% 6.5% 5.5% GAAP Net earnings $ 832.5 $ 428.0 $ 244.4 A s a perc ent age of revenue 6.7% 4.4% 3.1% Employee SBC expense 69.8 57.4 55.6 Amortization of intangible assets (excluding computer software) 39.8 38.8 36.8 Restructuring and other charges (recoveries) 29.7 19.4 12.1 IRS Transitional ADJ - - 9.0 Miscellaneous expense (income) 4.9 15.0 (46.6) TRS FVAs (253.0) (91.0) - FCC Transitional ADJ - (1.3) (1.2) Adjustments for taxes (20.5) (5.5) (14.3) Non-GAAP adjusted net earnings $ 703.2 $ 460.8 $ 295.8 A s a perc ent age of revenue 5.7% 4.8% 3.7% Non-GAAP adjusted earnings per share - diluted $ 6.05 $ 3.88 $ 2.46 GAAP Non-GAAP operating earnings (adjusted EBIAT) Non-GAAP adjusted net earnings and non-GAAP adjusted EPS (In millions of U.S. dollars, except percentages and per share amounts)Q1 2026 Q2 2026 Q3 2026 YTD 2026 FY 2025 FY 2024 FY 2023 GAAP Earnings from operations $ 272.1 $ 458.3 $ 460.0 $ 1,190.4 $ 1,040.7 $ 599.3 $ 338.3 Multiplier to annualize earnings 4 4 4 1.333 1 1 1 Annualized GAAP earnings from operations $ 1,088.4 $ 1,833.2 $ 1,840.0 $ 1,586.8 $ 1,040.7 $ 599.3 $ 338.3 Average Net Invested Capital for the period $ 2,611.4 $ 2,786.6 $ 3,066.6 $ 2,839.0 $ 2,498.7 $ 2,292.4 $ 2,132.5 GAAP ROIC % 41.7% 65.8% 60.0% 55.9% 41.6% 26.1% 15.9% Non-GAAP adjusted EBIAT $ 325.2 $ 386.3 $ 496.1 $ 1,207.6 $ 927.0 $ 622.6 $ 441.6 Multiplier to annualize earnings 4 4 4 1.333 1 1 1 Annualized non-GAAP adjusted EBIAT $ 1,300.8 $ 1,545.2 $ 1,984.4 $ 1,609.7 $ 927.0 $ 622.6 $ 441.6 Average Net Invested Capital for the period $ 2,611.4 $ 2,786.6 $ 3,066.6 $ 2,839.0 $ 2,498.7 $ 2,292.4 $ 2,132.5 Non-GAAP adjusted ROIC % 49.8% 55.5% 64.7% 56.7% 37.1% 27.2% 20.7% Net invested capital consists of: Total assets $ 8,260.0 $ 9,787.6 $ 15,138.5 $ 15,138.5 $ 7,213.1 $ 5,988.2 $ 5,890.5 Less: cash (378.0) (535.7) (3,961.3) (3,961.3) (595.6) (423.3) (370.4) Less: ROU assets (operating and finance leases) (199.9) (218.5) (274.5) (274.5) (173.1) (180.8) (170.0) (5,021.7) (6,120.7) (7,682.3) (7,682.3) (3,882.0) (2,969.2) (3,168.4) Net invested capital at period end $ 2,660.4 $ 2,912.7 $ 3,220.4 $ 3,220.4 $ 2,562.4 $ 2,414.9 $ 2,181.7 Non-GAAP adjusted ROIC Less: accounts payable, accrued and other liabilities and provisions (excluding finance and operating lease liabilities) and income taxes payable (In millions of U.S. dollars, except percentages)(In millions of U.S. dollars, except percentages) FY 2025 FY 2024 FY2023 GAAP tax expense $ 150.7 $ 104.2 $ 61.6 Earnings from operations 1,040.7 599.3 338.3 Finance costs (56.8) (57.0) (80.3) Interest income 4.2 4.9 1.4 Miscellaneous Income (Expense) (4.9) (15.0) 46.6 $ 983.2 $ 532.2 $ 306.0 GAAP effective tax rate1 15% 20% 20% Adjusted tax expense (non-GAAP) $ 171.2 $ 109.7 $ 75.9 Adjusted operating earnings (non-GAAP) 927.0 622.6 441.6 Finance costs (56.8) (57.0) (80.3) Interest income 4.2 4.9 1.4 IRS Transitional ADJ - - 9.0 $ 874.4 $ 570.5 $ 371.7 Adjusted effective tax rate (non-GAAP)2 20% 19% 20%27 Oct
  • 8-KResults of Operations and Financial Condition26 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Sep
  • 8-KEntry into a Material Definitive Agreement7 Aug
  • 8-KResults of Operations and Financial Condition27 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers6 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders19 May
  • 8-KEntry into a Material Definitive Agreement28 Apr
  • 8-KResults of Operations and Financial Condition27 Apr
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers24 Mar
  • 8-KOther Events29 Jan
  • 8-KResults of Operations and Financial Condition28 Jan
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers5 Dec 2025
  • 8-KRegulation FD Disclosure30 Oct 2025

Insider Ownership(165)

Expand
  • Form 4Ankenmann Todd5 Nov
  • Form 4Dorwart Steven Gregg5 Nov
  • Form 4Chawla Mandeep5 Nov
  • Form 4CASCELLA ROBERT1 Oct
  • Form 4Kale Jill1 Oct
  • Form 3Ankenmann Todd1 Oct
  • Form 4Cooper Todd C24 Sep
  • Form 4MIONIS ROBERT24 Sep
  • Form 4MIONIS ROBERT14 Aug
  • Form 4MIONIS ROBERT12 Aug
  • Form 4Reeder David12 Aug
  • Form 4Colpitts Christopher W.12 Aug
  • Form 4Maletira Amar12 Aug
  • Form 4KOELLNER LAURETTE T12 Aug
  • Form 4Kale Jill12 Aug

Beneficial Ownership(121)

Expand
  • SC 13G/ACELESTICA INC5 Feb
  • SC 13GCELESTICA INC21 Jan
  • SC 13G/ACELESTICA INC14 Aug 2025
  • SC 13G/ACELESTICA INC12 May 2025
  • SC 13G/ACELESTICA INC14 Feb 2025
  • SC 13G/ACELESTICA INC8 Jan 2025
  • SC 13GCELESTICA INC12 Nov 2024
  • SC 13G/ACELESTICA INC7 Nov 2024
  • SC 13GCELESTICA INC10 May 2024
  • SC 13G/ACELESTICA INC12 Feb 2024
  • SC 13GCELESTICA INC8 Feb 2024
  • SC 13G/ACELESTICA INC12 Jan 2024
  • SC 13G/ACELESTICA INC8 Sep 2023
  • SC 13D/ACELESTICA INC4 Aug 2023
  • SC 13G/ACELESTICA INC7 Jul 2023

Other Ownership(59)

Expand
  • Form 144Cooper Todd C23 Sep
  • Form 144Chawla Mandeep31 Jul
  • Form 144MIONIS ROBERT31 Jul
  • Form 144Chawla Mandeep15 Jun
  • Form 144MIONIS ROBERT15 Jun
  • Form 144Wilson Michael Max19 May
  • Form 144Muller Luis A23 Mar
  • Form 144Phillips Jason6 Feb
  • Form 144Etienvre Yann L2 Feb
  • Form 144Wong Leila2 Feb
  • Form 144Parker Douglas Michael2 Feb
  • Form 144Cooper Todd C2 Feb
  • Form 144Wong Leila1 Dec 2025
  • Form 144Etienvre Yann L1 Dec 2025
  • Form 144Agrawal Alok K.30 May 2025

Proxies(7)

Expand
  • ARSAnnual report to security holders9 Apr
  • DEFA14ADefinitive additional materials9 Apr
  • DEF 14ADefinitive proxy statement9 Apr
  • ARSAnnual report to security holders29 Apr 2025
  • DEFA14ADefinitive additional materials29 Apr 2025
  • DEF 14ADefinitive proxy statement29 Apr 2025
  • PRE 14APreliminary proxy statement7 Mar 2025

Registrations(52)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))6 Aug
  • FWPFree writing prospectus5 Aug
  • FWPFree writing prospectus5 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))5 Aug
  • S-8Registration statement (employee benefit plan)30 Jul 2025
  • S-8Registration statement (employee benefit plan)30 Jul 2025
  • S-3ASRAutomatic shelf registration statement (S-3)3 Mar 2025
  • S-8Registration statement (employee benefit plan)24 Oct 2024
  • 8-A12B/ARegistration of securities (Section 12(b), amendment)25 Apr 2024
  • 424B7Prospectus filing (Rule 424(b)(7))3 Aug 2023
  • 424B7Prospectus filing (Rule 424(b)(7))2 Aug 2023
  • S-8Registration statement (employee benefit plan)27 Jul 2023
  • F-3ASRAutomatic shelf registration statement (F-3)27 Jul 2023
  • 424B7Prospectus filing (Rule 424(b)(7))7 Jun 2023
  • 424B7Prospectus filing (Rule 424(b)(7))6 Jun 2023

Filing Review Correspondence(4)

Expand
  • CORRESPFiling review correspondence15 Sep 2016
  • CORRESPFiling review correspondence7 May 2015
  • CORRESPFiling review correspondence
  • CORRESPFiling review correspondence

SEC Orders And Notices(7)

Expand
  • CT ORDERConfidential treatment order3 Apr 2018
  • CT ORDERConfidential treatment order29 Mar 2017
  • CT ORDERConfidential treatment order11 Apr 2016
  • CT ORDERConfidential treatment order15 May 2015
  • CT ORDERConfidential treatment order23 Jun 2014
  • CT ORDERConfidential treatment order21 Jun 2013
  • CT ORDERConfidential treatment order12 Jun 2012

Tender Offers And Going Private(27)

Expand
  • SC TO-I/ATender offer statement (issuer, amendment)5 Jun 2015
  • SC TO-I/ATender offer statement (issuer, amendment)2 Jun 2015
  • SC TO-I/ATender offer statement (issuer, amendment)7 May 2015
  • SC TO-ISCHEDULE TO-I REG27 Apr 2015
  • SC TO-CTender offer statement (communication)21 Apr 2015
  • SC TO-CSC TO-I21 Apr 2015
  • SC TO-I/ATender offer statement (issuer, amendment)7 Dec 2012
  • SC TO-I/ATender offer statement (issuer, amendment)4 Dec 2012
  • SC TO-I/ASC TO-I19 Nov 2012
  • SC TO-I/ATender offer statement (issuer, amendment)6 Nov 2012
  • SC TO-ITender offer statement (issuer)29 Oct 2012
  • SC TO-CTender offer statement (communication)25 Oct 2012
  • SC TO-CTender offer statement (communication)24 Oct 2012
  • SC TO-I/ATender offer statement (issuer, amendment)8 Nov 2005
  • SC TO-I/ATender offer statement (issuer, amendment)8 Nov 2005

Other(14)

Expand
  • SDSD5 May
  • SDSD7 May 2025
  • SDSD5 May 2023
  • SDSD5 May 2022
  • SDSD6 May 2021
  • SDSD4 May 2020
  • SDSD13 May 2019
  • SDSD17 May 2018
  • SDSD26 May 2017
  • SDSD25 May 2016
  • SDSD22 May 2015
  • SDSD2 Jun 2014
  • Form 25AUTO-GENERATED PAPER DOCUMENT27 Sep 2005
  • SDSD